We are happy to announce the eight following renowned experts attending the 8th Edition of BBMS on the 11th of March 2016.
Executive Director – Wits Reproductive Health and HIV Institute, University of the Witwatersrand in Johannesburg
Honorary Professor in the Department of Infectious and Tropical Diseases of the Clinical Research Unit at the London School of Hygiene and Tropical Medicine
Prof Rees received her Medical Degree and a Masters in Social and Political Sciences from the University of Cambridge and is also an alumnus of Harvard Business School. Her research interests are focused on HIV/AIDS prevention, STIs, microbicides, HIV and HPV vaccines. Furthermore, she works in many international organisations such as the Global Alliance on Vaccines and Immunization, the HIV Vaccine Advisory Committee and the HPV Vaccine Expert Committee of the World Health Organization, the Population Council and the US National Institutes of Health.
Director of the Medical Research Council’s Centre for Neuropsychiatric Genetics and Genomics (Cardiff, UK)
Head of the Division of Psychological Medicine and Clinical Neurosciences in Cardiff University
Prof Sir Mike Owen’s research has focused on the genetics of major psychiatric and neurodegenerative disorders. He now aims to translate his genetic findings into a greater understanding of disease mechanisms and into the development of novel biomarkers to aid classification and diagnosis. He has published over 600 scientific papers and has been awarded several prestigious prizes for psychiatric and schizophrenia research. In addition, he continues to work as a Consultant in General Adult Psychiatry and was knighted for services to psychiatry and neuroscience in 2014.
Interim Head of Oncology iMed Unit and VP for Oncology Projects and Alliances for AstraZeneca
Dr Mortlock leads the delivery of the global small molecule oncology portfolio through to the start of Phase II pivotal studies. With extensive experience in leading and managing various groups, Dr Mortlock has spearheaded the development and delivery of several successful clinical candidates (e.g Aurora B kinase inhibitor, Osimertinib). His research interests include kinase inhibitors, breast cancer, lung cancer, acquired resistance and invasion/metastasis. Dr Mortlock has been an author on more than 50 peer reviewed papers or book chapters during his career.
Professor of Molecular Biology at the University of York and Director of the Yorkshire Cancer Research Unit, UK
Past chair – British Prostate Group and the European Society for Urological Research
Prof Maitland leads in his field with research into the development of novel therapeutic approaches for prostate cancer. Aside from investigating the biology behind prostate cancer, his lab also focuses on exploiting viruses for targeted gene therapy. Being the author of numerous academic articles he has been awarded many prizes for his work, such as the Chopin prize in 2009 for research excellence in his field. Finally, he founded his own biotech company (Pro-Cure Therapeutics) to exploit the translational output of the Cancer Research Unit and he is the author of key granted patents for the use of prostate cancer stem cells as therapeutic targets.
Professor Emerita, Department of Anatomy, University of California, San Francisco
Elected foreign Member of the Royal Society (ForMemRS), 2015
Prof Martin is world-leader in understanding the function of Fibroblast Growth Factors (FGFs) in vertebrate embryos. She was among the first to realize that growth factors are key molecules in mediating cell-cell interactions during development. She not only defined specific functions for FGFs but also established fundamental principles including how negative feedback mechanisms fine-tune signalling. She isolated pluripotent stem cells from early mouse embryos, working independently from another group who achieved this at the same time, and she coined the term “embryonic stem” cells.
Consultant in Oral, Maxillofacial and Head & Neck Surgery at St Bartholomew’s, The Royal London and Homerton University Hospitals in London.
Director of About Face Patients’ Support Group
Dr Cheng is consultant in Oral, Maxillofacial and Head & Neck Surgery. Besides his work at renowned Hospitals in London, he has been a regular volunteer as a Thyroid and Maxillofacial Reconstructive Surgeon on board the ‘Mercy Ships’ in West Africa offering life-saving and life-transforming surgery during his 2-3 weeks of annual leave for the last 8 years. Also, he is director of About Face Patients’ Support group, dedicated to patients who have had oral and maxillofacial surgery.
Reader & Lecturer in Cell Biology at the University of York, UK
Chief Scientific Officer and Founder of Cizzle Biotechnology Ltd
With her research mainly focusing on DNA metabolism, including DNA replication, repair and organisation, Dr Dawn Coverley is a leader in her field with a well-respected reputation globally. Her discovery of the Ciz1 protein and its role in DNA replication further revealed a specific protein variant implicated in lung cancer. For this, in 2005 she founded Cizzle Biotech Limited, a biotech company focusing on the CIZ1 gene and its potential use as a diagnostic biomarker for cancer.
Regius Professor of Chemistry, University of Glasgow
UK’s top 10 Inspiring Sciences and Engineers (EPSRC)
Prof Lee Cronin is pioneer of 3D-printing of drugs for diseases in the developing world. Much of his work is converging on exploring the assembly and engineering of emergent chemical systems aiming towards inorganic biology. Prof Cronin’s work has been presented in over 300 papers and 250 lectures worldwide. He was named one of the UK’s top 10 most inspirational scientists and engineers (RISE Leaders) in 2014 by the EPSRC.
For information about the speakers from previous years, please have a look at the Previous Years section.